1540-1405
Monthly
No
J NATL COMPR CANC NE
2003
134
UNITED STATES
偏慢,4-8周審稿時(shí)間
7.57影響因子
腫瘤學(xué)小學(xué)科
月期刊平臺(tái)服務(wù)過的文章錄用時(shí)間為1-3個(gè)月,依據(jù)20年經(jīng)驗(yàn),經(jīng)月期刊專家預(yù)審?fù)ㄟ^后的文章,投稿通過率100%以上!
全美超過24000名腫瘤學(xué)家和其他癌癥護(hù)理專家閱讀《國家綜合癌癥網(wǎng)絡(luò)雜志》(JNCCN)。這篇同行評(píng)審的索引醫(yī)學(xué)期刊提供了關(guān)于最佳臨床實(shí)踐、衛(wèi)生服務(wù)研究和轉(zhuǎn)化醫(yī)學(xué)的最新信息。JNCCN的特點(diǎn)是更新NCCN臨床實(shí)踐指南在腫瘤學(xué)?,(征求)綜述文章闡述指南的建議,衛(wèi)生服務(wù)研究,和病例報(bào)告強(qiáng)調(diào)在病人護(hù)理的分子洞察力。JNCCN的愿景是通過提供NCCN臨床實(shí)踐指南、轉(zhuǎn)化醫(yī)學(xué)創(chuàng)新和腫瘤健康服務(wù)研究相關(guān)科學(xué)研究(包括質(zhì)量護(hù)理和價(jià)值、患者結(jié)果和公共政策)信息的主要資源,進(jìn)一步推動(dòng)NCCN的使命。JNCCN由medline/pubmed、化學(xué)文摘、embase、emcare和scopus編制索引。JNCCN的2017年影響因子為6.471。JNCN致力于提高本地、全國和國際癌癥護(hù)理質(zhì)量,同時(shí)加強(qiáng)學(xué)術(shù)醫(yī)學(xué)和社區(qū)醫(yī)生之間的合作。JNCN還致力于通過發(fā)布臨床實(shí)踐指南、指導(dǎo)意見、見解和報(bào)告嚴(yán)格的衛(wèi)生服務(wù)研究,在整個(gè)癌癥護(hù)理體系中傳播信息。JNCN還為通信和評(píng)論提供了一個(gè)論壇。關(guān)于JNCCN繼續(xù)教育項(xiàng)目的最新信息,請(qǐng)通過abrody@harborsidemeded.com聯(lián)系A(chǔ)lana Brody。
http://www.editorialmanager.com/jnccn/default.aspx
More than 24,000 oncologists and other cancer care professionals across the United States read JNCCN–Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about best clinical practices, health services research, and translational medicine. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology?, (solicited) review articles elaborating on guideline recommendations, health services research, and case reports highlighting molecular insights in patient care.JNCCN's vision is to further the mission of NCCN by serving as the primary resource for information on NCCN Clinical Practice Guidelines, innovation in translational medicine, and on scientific studies related to oncology health services research, including quality care and value, patient outcomes, and public policy.JNCCN is indexed by MEDLINE/PUBMED, Chemical Abstracts, EMBASE, EMCare, and Scopus.The 2017 Impact Factor for JNCCN is 6.471.*JNCCN is dedicated to improving the quality of cancer care locally, nationally, and internationally while enhancing the collaboration between academic medicine and the community physician. JNCCN is further committed to disseminating information across the cancer care continuum by publishing clinical practice guidelines, guidelines insights, and reporting rigorous health services research.JNCCN also provides a forum for correspondence and commentary.UPDATE For information about continuing education programs in JNCCN, please contact Alana Brody at abrody@harborsidemeded.com.
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會(huì)議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊